StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for ELMD yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-14 | $34.74 | $36.50 | +5.07% | 0.1M |
| 05-15 | $35.92 | $35.68 | -0.67% | 0.2M |
| 05-18 | $35.89 | $38.24 | +6.55% | 0.1M |
| 05-19 | $38.76 | $38.37 | -1.01% | 0.1M |
| 05-20 | $38.37 | $37.74 | -1.64% | 0.1M |
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $54.36M | $35.78M | $16.89M | $64.00M |
Operating Income | $10.06M | $6.29M | $2.67M | $9.66M |
Net Income | $7.90M | $2.76M | $2.14M | $7.54M |
EPS (Diluted) | $0.91 | $0.56 | $0.25 | $0.85 |
Total Assets | $59.47M | $54.91M | $53.61M | $53.80M |
Total Liabilities | $10.31M | $9.47M | $8.87M | $10.59M |
Cash & Equivalents | $16.98M | $13.79M | $14.11M | $15.29M |
Free Cash Flow OCF − CapEx | $5.64M | $2.31M | $-83.00K | $11.13M |
Shares Outstanding | 8.28M | 8.28M | 8.36M | 8.35M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.